Nanotechnology synergized immunoengineering for cancer.

MLA

Chauhan, Deepak S., et al. “Nanotechnology Synergized Immunoengineering for Cancer.” European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, vol. 163, June 2021, pp. 72–101. EBSCOhost, https://doi.org/10.1016/j.ejpb.2021.03.010.

APA

Chauhan, D. S., Dhasmana, A., Laskar, P., Prasad, R., Jain, N. K., Srivastava, R., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2021). Nanotechnology synergized immunoengineering for cancer. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 163, 72–101. https://doi.org/10.1016/j.ejpb.2021.03.010

Chicago

Chauhan, Deepak S, Anupam Dhasmana, Partha Laskar, Rajendra Prasad, Nishant K Jain, Rohit Srivastava, Meena Jaggi, Subhash C Chauhan, and Murali M Yallapu. 2021. “Nanotechnology Synergized Immunoengineering for Cancer.” European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 163 (June): 72–101. doi:10.1016/j.ejpb.2021.03.010.